HH

Holger Heitsch

Hoechst Gmbh: 12 patents #295 of 4,020Top 8%
AG Aventis Pharma Deutschland Gmbh: 11 patents #23 of 418Top 6%
SA Sanofi-Aventis: 5 patents #260 of 1,008Top 30%
SA Sanofi-Aventis: 1 patents #285 of 563Top 55%
RU Roussel Uclaf: 1 patents #224 of 430Top 55%
HG Hoechst Marion Roussel Deutschland Gmbh: 1 patents #7 of 62Top 15%
SA Sanofi: 1 patents #1,013 of 1,881Top 55%
Overall (All Time): #103,698 of 4,157,543Top 3%
34
Patents All Time

Issued Patents All Time

Showing 25 most recent of 34 patents

Patent #TitleCo-InventorsDate
8710232 Imidazole derivatives used as TAFIa inhibitors Christopher Kallus, Andreas Lindenschmidt, Sven Grueneberg, Hauke Szillat 2014-04-29
8586612 Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them Stephanie Hachtel, Heinrich Englert, Uwe Gerlach, Heinz GOEGELEIN, Karl-Heinz Lehr +1 more 2013-11-19
8501981 CXCR2 inhibitors Stephanie Hachtel, Juergen Dedio, Elisabeth Defossa, Sven Grueneberg, William Jerome Bock +7 more 2013-08-06
8283479 CXCR2 inhibitors Stephanie Hachtel, Juergen Dedio, Werngard Czechtizky, Sven Grueneberg, Stephen Shimshock +5 more 2012-10-09
8044208 Imidazole derivatives as inhibitors of TAFIa Christopher Kallus, Volkmar Wehner 2011-10-25
7919628 CXCR2 inhibitors Stephanie Hachtel, Juergen Dedio, Werngard Czechtizky, Sven Grueneberg, Stephen Shimshock +5 more 2011-04-05
7550257 Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels Hans-Willi Jansen, Andrea Brüggeman, Heinz Gogelein 2009-06-23
6984660 P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparation and use 2006-01-10
6979532 Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels Hans-Willi Jansen, Andrea Bruggemann, Heinz Gogelein 2005-12-27
6538144 P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparation and use 2003-03-25
6511989 Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them Heinrich Englert 2003-01-28
6472413 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them Heinrich Englert 2002-10-29
6462024 Use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substrates of the heart Hans-Jochen Lang, Hartmut Rutten, Wolfgang Linz, Bernward Scholkens 2002-10-08
6429222 1-(p-thienylbenzyl)imidazoles as agonists of angiotensin (1-7) receptors, processes for their preparation, their use, and pharmaceutical preparations comprising them Gabriele Wiemer 2002-08-06
6414030 Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptors blockers Klaus Wirth, Heinrich Englert, Helmut Bohn, Heinz Gogelein, Uwe Gerlach 2002-07-02
6410573 2,5-substituted benzolsulfonylureas and thioureas methods for the production thereof use thereof and pharmaceutical preparations containing the same Heinrich Englert, Heinz Gogelein 2002-06-25
6350778 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, processes for their preparation, their use, and pharmaceutical preparations comprising them Heinrich Englert, Klaus Wirth, Heinz Gogelein 2002-02-26
6245736 Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's disease Stephan Henke, Gerhard Breipohl, Jochen Knolle, Klaus Wirth, Gabriele Wiemer 2001-06-12
6235766 1-(p-thienylbenzyl)imidazoles as agonists of angiotensin (1-7) receptors, processes for their preparation, their use, and pharmaceutical preparations comprising them Gabriele Wiemer 2001-05-22
6211196 Benzyloxy-substituted, fused N-heterocycles, processes for their preparation, and their use as bradykinin receptor antagonists Adalbert Wagner, Klaus Wirth, Bernward Scholkens 2001-04-03
6140341 Aminoalkyl and acylaminoalkyl ethers, process for their preparation, and their use as bradykinin receptor antagonists Adalbert Wagner, Klaus Wirth, Bernward Scholkens, Gerhard Nolken 2000-10-31
5952346 Use of non-peptide bradykinin antagonists for the treatment or prevention of Alzheimer's disease Klaus Wirth, Gabriele Wiemer 1999-09-14
5859025 Fluoroalkyl- and fluoroalkoxy-substituted heterocyclic bradykinin antagonists, process for their preparation, and their use Adalbert Wagner, Gerhard Nolken, Klaus Wirth, Bernward Scholkens 1999-01-12
5834500 Sulfur-containing heterocyclic bradykinin antagonists, process for their preparation, and their use Adalbert Wagner, Gerhard Nolken, Klaus Wirth, Bernward Scholkens 1998-11-10
5786365 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith Adalbert Wagner, Klaus Wirth, Max Hropot, Martin Bickel 1998-07-28